» Articles » PMID: 14501005

Effects of Lipophilicity on the Affinity and Nonspecific Binding of Iodinated Benzothiazole Derivatives

Overview
Journal J Mol Neurosci
Date 2003 Sep 23
PMID 14501005
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aseries of novel 2-aryl benzothiazole derivates substituted with iodine in different positions have been synthesized as amyloid-binding ligands. The affinity of these compounds for synthetic amyloid beta (1-40) (Abeta[1-40]) fibrils was determined. Introduction of the iodo group in the position ortho to an amino group increased the binding affinity, whereas the iodination ortho to a hydroxyl group decreased the binding affinity. Selected compounds with high binding affinity and moderate lipophilicity (logP values, 1.65-3.90) were radiolabeled and evaluated in normal mice for brain uptake and clearance. Structure-activity relationship (SAR) studies showed a strong correlation between the lipophilicity of the iodinated compounds and the binding affinity as well as nonspecific binding. As the lipophilicity increased, the affinity for Abeta(1-40) fibrils improved; however, nonspecific binding in mouse brain reflected by low brain clearance also increased with increasing lipophilicity. These results provide important SAR information to guide the development of novel amyloid-binding agents and provide further insights into the molecular interaction between 2-aryl benzothiazole ligands and Abeta fibrils.

Citing Articles

Revealing Propolis Potential Activity on Inhibiting Estrogen Receptor and Heat Shock Protein 90 Overexpressed in Breast Cancer by Bioinformatics Approaches.

Simanjuntak M, Jauhar M, Syaifie P, Arda A, Mardliyati E, Shalannanda W Bioinform Biol Insights. 2024; 18:11779322231224187.

PMID: 38274992 PMC: 10809879. DOI: 10.1177/11779322231224187.


Synthesis, antitumor activity, 3D-QSAR and molecular docking studies of new iodinated 4-(3)-quinazolinones 3-substituted.

Perez-Fehrmann M, Kesternich V, Puelles A, Quezada V, Salazar F, Christen P RSC Adv. 2022; 12(33):21340-21352.

PMID: 35975048 PMC: 9344282. DOI: 10.1039/d2ra03684c.


Salicylate metal-binding isosteres as fragments for metalloenzyme inhibition.

Jackl M, Seo H, Karges J, Kalaj M, Cohen S Chem Sci. 2022; 13(7):2128-2136.

PMID: 35308862 PMC: 8849047. DOI: 10.1039/d1sc06011b.


Direct catalytic arylation of heteroarenes with -bromophenyl-substituted porphyrins.

Kiselev A, Grigorova O, Averin A, Syrbu S, Koifman O, Beletskaya I Beilstein J Org Chem. 2017; 13:1524-1532.

PMID: 28845197 PMC: 5550796. DOI: 10.3762/bjoc.13.152.


Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents.

Zayed M, Hassan M Saudi Pharm J. 2014; 22(2):157-62.

PMID: 24648828 PMC: 3950501. DOI: 10.1016/j.jsps.2013.03.004.


References
1.
Selkoe D . Imaging Alzheimer's amyloid. Nat Biotechnol. 2000; 18(8):823-4. DOI: 10.1038/78422. View

2.
Wang Y, Klunk W, Huang G, Debnath M, Holt D, Mathis C . Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease. J Mol Neurosci. 2002; 19(1-2):11-6. DOI: 10.1007/s12031-002-0004-8. View

3.
Klunk W, Wang Y, Huang G, Debnath M, Holt D, Shao L . The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci. 2003; 23(6):2086-92. PMC: 6741999. View

4.
Wengenack T, Curran G, Poduslo J . Targeting alzheimer amyloid plaques in vivo. Nat Biotechnol. 2000; 18(8):868-72. DOI: 10.1038/78482. View

5.
Bard F, Cannon C, Barbour R, Burke R, Games D, Grajeda H . Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000; 6(8):916-9. DOI: 10.1038/78682. View